Merck Makes Senior Management Changes
Kenneth Frazier, currently president of the company's Global Human Health worldwide sales and marketing division, was elected company president by the Merck board of directors, reporting to Mr Clark.
Adam Schechter, who currently leads the company's pharmaceutical business in the US, was elected to succeed Mr Frazier as president of Global Human Health.
Mr Clark, chairman, CEO and president of Merck, said: “Mr Ken is a leader with deep knowledge about our company and the industry who has real passion for Merck's role in saving and improving lives through scientific innovation. Merck's board and I have the utmost confidence in Mr Ken's ability to help navigate Merck during a time of unprecedented change and enormous opportunity in the global health care industry.”
Will Merck benefit with these changes?
Have your say and discuss with your peers on the InfoGrok community.
Participate by posting your comments now.